Home › Diffuse Large B-Cell Lymphoma › Ohio › Cleveland

Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Cleveland, OH

Isang pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Cleveland. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Nagre-recruitPhase 3

University Hospitals Cleveland Medical Center, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06091865

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Nagre-recruitPhase 2

University Hospitals of Cleveland ( Site 0155), Cleveland
Fairview Hospital-Moll Cancer Center ( Site 0198), Cleveland
Cleveland Clinic Main ( Site 0101), Cleveland
at 1 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06890884

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Nagre-recruitPhase 1

Cleveland Clinic, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Nagre-recruitPhase 1

Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, Cleveland
Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07225439

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Nagre-recruitPhase 2

Cleveland Clinic, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT06500273

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Nagre-recruitPhase 1/2

Cleveland Clinic, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Nagre-recruitPhase 3

Cleveland Clinical Taussig Cancer Center, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Nagre-recruitPhase 1

Case Western Reserve University, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT06015880

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

Cleveland Clinic, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05131022

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Nagre-recruitPhase 2

Case Western Reserve University, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 2, 2026 · NCT05633615

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Nagre-recruitPhase 1

University Hospitals Cleveland Medical Center, Cleveland

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2025 · NCT05780034

Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Cleveland

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.